TerrAscend (TSNDF) Accounts Payables (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Accounts Payables of $40.0 million for Q1 2026, down 9.57% year-over-year from $44.2 million in Q1 2025, and little changed quarter-over-quarter from $39.8 million in Q4 2025.
TerrAscend (TSNDF) Accounts Payables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Accounts Payables for 6 consecutive years, with $40.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 9.57% year-over-year to $40.0 million; the TTM figure through Mar 2026 stood at $40.0 million (down 9.57% YoY), while the FY2025 annual figure was $39.8 million, down 1.34% from the prior year.
- Accounts Payables steadied at $40.0 million in Q1 2026 per TSNDF's latest filing, from $39.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $61.7 million in Q3 2022 and bottomed at $36.0 million in Q3 2025.
- Historically, Accounts Payables has averaged $46.8 million across 5 years, with a median of $46.9 million in 2024.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 58.6% — and 2025, when it retreated 22.4%.
- TerrAscend's Accounts Payables stood at $44.3 million in 2022, then climbed by 12.67% to $49.9 million in 2023, then retreated by 19.14% to $40.3 million in 2024, then declined by 1.34% to $39.8 million in 2025, then gained by 0.43% to $40.0 million in 2026.
- Business Quant data shows TSNDF's Accounts Payables at $40.0 million in Q1 2026, $39.8 million in Q4 2025, and $36.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 40.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.13 Mn |
| Mar 31, 2026 | 39.98 Mn |
| Dec 31, 2025 | 39.81 Mn |
| Sep 30, 2025 | 35.99 Mn |
| Jun 30, 2025 | 37.01 Mn |
| Mar 31, 2025 | 44.21 Mn |
| Dec 31, 2024 | 40.35 Mn |
| Sep 30, 2024 | 46.38 Mn |
| Jun 30, 2024 | 46.92 Mn |
| Mar 31, 2024 | 49.67 Mn |
| Dec 31, 2023 | 49.90 Mn |
| Sep 30, 2023 | 51.03 Mn |
| Jun 30, 2023 | 50.84 Mn |
| Mar 31, 2023 | 50.78 Mn |
| Dec 31, 2022 | 44.29 Mn |
| Sep 30, 2022 | 61.68 Mn |
| Jun 30, 2022 | 57.54 Mn |
| Mar 31, 2022 | 49.21 Mn |
| Dec 31, 2021 | 27.92 Mn |